Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for November 30th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 30th:

Splunk Inc. : This software solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.

Splunk Inc. Price and Consensus

Splunk Inc. Price and Consensus

Splunk Inc. price-consensus-chart | Splunk Inc. Quote

Splunk’s shares gained 19.3% over the last one month more than S&P 500’s gain of 1.7%. The company possesses a Momentum Score of A.

Cognex Corporation (CGNX - Free Report) : This machine vision products provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 5.7% over the last 60 days.

Cognex’s shares gained 8.3% over the last one month. The company possesses a Momentum Score of A.

Luxoft Holding, Inc. : This software development services provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

Luxoft Holding’s shares gained 20% over the last one month. The company possesses a Momentum Score of A.

Maxwell Technologies, Inc. : This energy storage and power delivery products designer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.8% over the last 60 days.

Maxwell Technologies’ shares gained 21.6% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Cognex Corporation (CGNX) - free report >>